Bristol-Myers Squibb Company (BMY) Shareholder/Analyst Call Transcript [Seeking Alpha]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Seeking Alpha
Kate Bender Cristian Massacesi - Executive VP, Chief Medical Officer & Head of Development Lynelle Hoch - President of Cell Therapy Organization Rosanna Ricafort Monica Shaw Conference Call Participants Mary Kate Davis Matthew Phipps - William Blair & Company L.L.C., Research Division Luisa Hector - Joh. Berenberg, Gossler & Co. KG, Research Division Steve Scala - TD Cowen, Research Division Courtney Breen - Sanford C. Bernstein & Co., LLC., Research Division David Amsellem - Piper Sandler & Co., Research Division Zachary Dunn - Guggenheim Securities, LLC, Research Division Kripa Devarakonda Presentation Operator Welcome to the Bristol-Myers Squibb Hematology Drug Development Update Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Kate Bender, Investor Relations. Please go ahead. Kate Bender Good morning. This is Kate Bender from Bristol-Myers Squibb, Investor Relatio
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Is Bristol-Myers Squibb a Value Opportunity After 5.1% Rebound and DCF Outlook? [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (NYSE:BMY) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- Quebec becomes first province in Canada to list new subcutaneous OPDIVO® on public drug plan for solid tumour indications [Yahoo! Finance]Yahoo! Finance
- How the Narrative Surrounding Bristol Myers Squibb Is Shifting After Recent Sector and Policy Updates [Yahoo! Finance]Yahoo! Finance
- Fusion Proteins Market to Hit $64.9 Billion by 2030 [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 10/31/25 - Beat
BMY
Sec Filings
- 11/18/25 - Form 8-K
- 11/12/25 - Form CERT
- 11/10/25 - Form 8-A12B
- BMY's page on the SEC website